Supernus Pharmaceuticals
SUPN
#4465
Rank
NZ$3.05 B
Marketcap
$54.75
Share price
0.87%
Change (1 day)
-2.61%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.78 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company has NZ$0.78 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Supernus Pharmaceuticals - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.80 B99.57%
2023-12-31NZ$0.40 B-44.53%
2022-12-31NZ$0.72 B46.11%
2021-12-31NZ$0.49 B-15.08%
2020-12-31NZ$0.58 B13.63%
2019-12-31NZ$0.51 B-2.9%
2018-12-31NZ$0.53 B169.17%
2017-12-31NZ$0.19 B51.56%
2016-12-31NZ$0.13 B43.18%
2015-12-31NZ$90.86 M-4.23%
2014-12-31NZ$94.87 M-5.14%
2013-12-31NZ$0.10 B-7.04%
2012-12-31NZ$0.10 B72.98%
2011-12-31NZ$62.19 M46.73%
2010-12-31NZ$42.39 M-53.72%
2009-12-31NZ$91.59 M-11.97%
2008-12-31NZ$0.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.68 B 620.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.96 B 654.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.91 B 2,293.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.87 B 1,656.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$42.70 B 5,305.94%๐Ÿ‡บ๐Ÿ‡ธ USA